Chapin Davis Inc. Takes $2.23 Million Position in DaVita Inc. (NYSE:DVA)

Chapin Davis Inc. acquired a new stake in shares of DaVita Inc. (NYSE:DVA) in the second quarter, HoldingsChannel.com reports. The firm acquired 16,075 shares of the company’s stock, valued at approximately $2,228,000. DaVita comprises about 0.8% of Chapin Davis Inc.’s investment portfolio, making the stock its 27th biggest holding.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Blue Trust Inc. raised its holdings in DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after purchasing an additional 78 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in DaVita during the 4th quarter valued at approximately $30,000. Principal Securities Inc. purchased a new position in shares of DaVita in the fourth quarter worth $37,000. Versant Capital Management Inc lifted its stake in DaVita by 90.6% in the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after purchasing an additional 155 shares in the last quarter. Finally, Friedenthal Financial bought a new position in DaVita during the second quarter valued at approximately $48,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insider Activity at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total value of $1,148,771.97. Following the completion of the transaction, the insider now owns 83,011 shares of the company’s stock, valued at $12,137,038.31. The transaction was disclosed in a filing with the SEC, which is available at this link. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

DVA has been the subject of several research reports. Barclays increased their price objective on shares of DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research report on Monday, May 6th. Truist Financial increased their target price on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a research note on Wednesday, May 15th. StockNews.com downgraded shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. TD Cowen lifted their price objective on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. Finally, Bank of America increased their target price on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $154.00.

DaVita Stock Up 0.2 %

Shares of DVA traded up $0.34 during trading hours on Friday, hitting $150.30. The company had a trading volume of 680,482 shares, compared to its average volume of 720,697. DaVita Inc. has a one year low of $71.51 and a one year high of $151.55. The company’s fifty day moving average price is $140.32 and its two-hundred day moving average price is $135.14. The company has a market capitalization of $13.18 billion, a PE ratio of 17.08, a price-to-earnings-growth ratio of 0.86 and a beta of 0.87. The company has a current ratio of 1.16, a quick ratio of 1.12 and a debt-to-equity ratio of 9.94.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. During the same period in the previous year, the company earned $2.08 earnings per share. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, equities analysts forecast that DaVita Inc. will post 9.9 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.